The market is expected to expand at a CAGR of 19.8% from 2025 to 2033. Plasmid DNA plays a crucial role in gene therapy, vaccine production, and the development of biopharmaceuticals, making it an ...

This allows scientists to screen different payload and packaging combinations and ensure that they have generated an optimal gene therapy. To ensure they have the materials required for each testing ...

The global plasmid DNA manufacturing market is entering a transformative era, driven by revolutionary advancements in gene therapy, cancer immunotherapy, DNA vaccines, and other cell and gene-based ...

The most common used applications for plasmids within the Biopharmaceutical space are bacterial vector Cloning, Protein Production, Gene Therapy and different Disease Models, which is in line with ...

A new study in the journal Human Gene Therapy indicates that DNA impurities derived from plasmid and host cell DNA are encapsulated into recombinant adeno-associated virus (rAAV) capsids as single ...

To address this gap, the study leveraged 64,000 fully synthetic DNA sequences ... shut that gene down when they occur together. The results could provide a new tool for gene-therapy developers ...

The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching ...

Elegen launches Early Access for ENFINIA IVT Ready DNA, complete with a long poly(A) tail, delivered fast & ready for ...

Compared to viral methods commonly used for gene therapy, these DNA-LNPs can carry larger genetic instructions, cause fewer immune reactions, target specific cells more precisely, and can be given ...